KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Interest Expenses (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Interest Expenses data on record, last reported at $23.8 million in Q4 2025.

  • For Q4 2025, Interest Expenses fell 15.79% year-over-year to $23.8 million; the TTM value through Dec 2025 reached $107.0 million, down 15.25%, while the annual FY2025 figure was $107.0 million, 15.25% down from the prior year.
  • Interest Expenses reached $23.8 million in Q4 2025 per CRL's latest filing, down from $25.4 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $35.0 million in Q3 2023 and bottomed at $3.7 million in Q2 2022.
  • Average Interest Expenses over 5 years is $25.2 million, with a median of $29.0 million recorded in 2021.
  • Peak YoY movement for Interest Expenses: crashed 77.13% in 2022, then skyrocketed 846.37% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $11.5 million in 2021, then surged by 201.22% to $34.8 million in 2022, then decreased by 3.55% to $33.5 million in 2023, then dropped by 15.83% to $28.2 million in 2024, then decreased by 15.79% to $23.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $23.8 million in Q4 2025, $25.4 million in Q3 2025, and $30.0 million in Q2 2025.